Your search for comorbidities returned 10 results

The researchers’ goal was to determine the clinical impact of stent graft thrombosis and its prognosis.

SAFE-PAD evaluated the real-world safety of femoropopliteal artery revascularization using drug-coated vs non-drug-coated devices.

A systematic review and meta-analysis was conducted to look at the effects of body mass index on atrial fibrillation‐related outcomes in anticoagulated patients.

Researchers assessed the clinical usefulness of specific biomarkers in risk stratification for vascular complications Identifying biomarkers that predict risk for pulmonary hypertension or ischemic digital lesions may be useful in monitoring the development of systemic sclerosis in patients.

Women who smoke may be at higher risk of developing abdominal aortic aneurysm compared with men who do not smoke.

The risk for death in patients undergoing anticoagulation therapy for venous thromboembolism was found to be lower in those who were morbidly obese vs those who had normal weight.

The duration of carotid blood flow reversal during transcarotid artery revascularization for carotid bifurcation stenosis was not found to affect the rate of stroke, myocardial infarction, or death.

The risk for a cardiac event was found to be greater in patients with peripheral artery disease vs coronary artery disease.

Patients with vs without chronic kidney disease were found to have more comorbidities and complex lesions after receiving new-generation drug-eluting stents.

Investigators examined the relationship between trends in primary and secondary vascular access sites and vascular access site complications among a cohort of patients who underwent PCI.